| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5583091 | Journal of Clinical Anesthesia | 2017 | 8 Pages |
Abstract
Sugammadex administered at recommended doses provides rapid and predictable reversal of rocuronium and vecuronium-induced moderate and deep NMB, and effective reversal 3Â min after rocuronium 1.2Â mg/kg. Robust recovery was seen across various patient factors, providing further confirmation of labeled dose recommendations.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
William Joseph MD, PhD, Tiffany MS, Christopher A. PhD, Robert J. MS, Hendrikus J. PhD, Manfred MD, Karin S. PhD,